Natus Medical, Inc. (BABY) Misses Q2 EPS by 1c; Lowers FY11 Outlook
Tweet
Share
E-mailGet Alerts BABY Hot Sheet
Price: $26.75 --0%
Financial Fact:
Marketing and selling: 19.75M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Marketing and selling: 19.75M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Natus Medical, Inc. (NASDAQ: BABY) reported Q2 EPS of $0.13, $0.01 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $58.1 million versus the consensus estimate of $57.93 million.
Natus Medical, Inc. sees FY2011 EPS of $0.58-$0.60, versus prior guidance of $0.80-$0.81 and the consensus of $0.74. Natus Medical, Inc. sees FY2011 revenue of $236 million, versus prior guidance of $250 million and the consensus of $243.36 million.
Natus Medical, Inc. sees FY2011 EPS of $0.58-$0.60, versus prior guidance of $0.80-$0.81 and the consensus of $0.74. Natus Medical, Inc. sees FY2011 revenue of $236 million, versus prior guidance of $250 million and the consensus of $243.36 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
- Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
